Literature DB >> 25945722

Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases.

Sergio Martín, Ainhoa Ruiz del Agua, Nerea Torres, Dora Pascual-Salcedo, Chamaida Plasencia, Begoña Ruiz-Argüello, Antonio Martínez, Rosaura Navarro, Daniel Nagore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25945722     DOI： 10.1515/cclm-2015-0266

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  5 in total

Review 1.  Golimumab pharmacokinetics in ulcerative colitis: a literature review.

Authors:  Ines Harzallah; Josselin Rigaill; Nicolas Williet; Stephane Paul; Xavier Roblin
Journal:  Therap Adv Gastroenterol       Date:  2016-11-15       Impact factor: 4.409

2.  Assays for measurement of TNF antagonists in practice.

Authors:  Niels Vande Casteele
Journal:  Frontline Gastroenterol       Date:  2016-03-08

Review 3.  Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

Authors:  Niels Vande Casteele; Reena Khanna
Journal:  Pharm Res       Date:  2017-04-03       Impact factor: 4.200

Review 4.  Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.

Authors:  Charlotte Krieckaert; Borja Hernández-Breijo; Johanna Elin Gehin; Guillaume le Mélédo; Alejandro Balsa; Meghna Jani; Denis Mulleman; Victoria Navarro-Compan; Gertjan Wolbink; John Isaac; Astrid van Tubergen
Journal:  RMD Open       Date:  2022-06

Review 5.  Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?

Authors:  Nathalie Van den Berghe; Ann Gils; Debby Thomas
Journal:  Clin Pharmacol Ther       Date:  2019-09-20       Impact factor: 6.875
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.